Validation, the Key to Translatable Flow Cytometry, Part 2: Method Validation - Planning and Executing

Validation, the Key to Translatable Flow Cytometry, Part 2: Method Validation - Planning and Executing

Recorded On: 09/10/2018

Back to Package

  • Register
    • Non-member - Free!
    • Full - Free!
    • Student - Free!
    • SRL Junior Staff - Free!
    • SRL Emerging Leader - Free!
    • Scholar - Free!
    • Emeritus - Free!
    • Life - Free!
    • ISAC Staff - Free!
    • Community Administrator - Free!
    • Student Non-Member - Free!
    • SRL Junior Staff Non-member - Free!
    • Innovator - Free!

About the Presenter


Teri Oldaker
Clinical Laboratory Consultant

Teri is a licensed clinical laboratory scientist and certified cytometrist with over 40 years clinical laboratory and 34 years flow cytometry experience in reference laboratory settings.  She is currently in a consultant role for a number of clinical laboratories. Her prior roles include director of flow cytometry at Genoptix, Neogenomics, Genzyme Genetics, and Nichols Institute. Teri has served on the board of the International Clinical Cytometry Society (ICCS) as secretary/treasurer and councilor, and is on the faculty of both the ICCS and Clinical Cytometry Education Network (CCEN) Flow Courses. She is a member of the following ICCS committees: Advocacy, Certification, and Quality and Standards Committees. She has authored four book chapters and over 40 publications in the field of flow cytometry.

Webinar Description

This webinar will review the specifics on how to conduct a validation. We will begin with an introduction of the various regulated environments and accreditation bodies requiring assay validation. Then we will discuss how to conduct the appropriate validation for each environment. The distinction between assay qualification and validation will be reviewed. Various strategies to designing method validation protocols will be discussed. These recommendations will be aligned with the upcoming Clinical Laboratories Standards Institute (CLSI) guidelines regarding the number of samples, number of analytical runs, data analysis, and acceptance criteria. Examples of a biomarker validation and a clinical laboratory validation will be presented. Lastly, an update on the progress of a regulatory guidance document for the validation of flow cytometric methods will be presented.

Learning Objectives

In the second webinar of the series, you will learn the how to convert the principles learned in the first webinar into practice in your own laboratory. We will describe what you actually need to do to validate a method.

  • An introduction to the different types of regulatory environments.
  • Gain an understanding of the difference between assay development, optimization, and validation.
  • Gain an understanding of the fit-for-purpose and context-of-use validation approaches.
  • Learn to prepare user-friendly documentation.

Who Should Attend

Anyone using flow cytometry who wants to generate high-quality data.

CMLE Credit: 1.0


Validation, the Key to Translatable Flow Cytometry, Part 2: Method Validation - Planning and Executing
Recorded 09/10/2018
Recorded 09/10/2018 A CYTO U Webinar presented by Teri Oldaker
Open to download resource.
Open to download resource.
CMLE Evaluation Form
11 Questions
11 Questions CMLE Evaluation Form
Completion Credit
1.00 CMLE credit  |  Certificate available
1.00 CMLE credit  |  Certificate available